nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—muscle cancer—hematologic cancer	0.12	1	CtDrD
Doxorubicin—Daunorubicin—hematologic cancer	0.0943	0.475	CrCtD
Doxorubicin—Idarubicin—hematologic cancer	0.0715	0.36	CrCtD
Doxorubicin—Anthracyclines—Daunorubicin—hematologic cancer	0.0563	0.218	CiPCiCtD
Doxorubicin—Anthracyclines—Idarubicin—hematologic cancer	0.0427	0.165	CiPCiCtD
Doxorubicin—Epirubicin—hematologic cancer	0.0328	0.165	CrCtD
Doxorubicin—Topoisomerase Inhibitors—Daunorubicin—hematologic cancer	0.0294	0.114	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Teniposide—hematologic cancer	0.025	0.0968	CiPCiCtD
Doxorubicin—NQO1—hematologic cancer	0.0233	0.298	CbGaD
Doxorubicin—ABCC3—hematologic cancer	0.0229	0.293	CbGaD
Doxorubicin—Topoisomerase Inhibitors—Idarubicin—hematologic cancer	0.0223	0.0863	CiPCiCtD
Doxorubicin—Idarubicin—Daunorubicin—hematologic cancer	0.0202	0.158	CrCrCtD
Doxorubicin—Valrubicin—Daunorubicin—hematologic cancer	0.0202	0.158	CrCrCtD
Doxorubicin—Epirubicin—Daunorubicin—hematologic cancer	0.0202	0.158	CrCrCtD
Doxorubicin—Anthracyclines—Epirubicin—hematologic cancer	0.0196	0.0758	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Irinotecan—hematologic cancer	0.019	0.0734	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Mitoxantrone—hematologic cancer	0.019	0.0734	CiPCiCtD
Doxorubicin—TOP2A—hematologic cancer	0.0163	0.208	CbGaD
Doxorubicin—Epirubicin—Idarubicin—hematologic cancer	0.0153	0.12	CrCrCtD
Doxorubicin—Valrubicin—Idarubicin—hematologic cancer	0.0153	0.12	CrCrCtD
Doxorubicin—Daunorubicin—Idarubicin—hematologic cancer	0.0153	0.12	CrCrCtD
Doxorubicin—Topoisomerase Inhibitors—Etoposide—hematologic cancer	0.0149	0.0576	CiPCiCtD
Doxorubicin—YWHAG—Daunorubicin—hematologic cancer	0.0111	0.0853	CbGbCtD
Doxorubicin—ABCG2—hematologic cancer	0.0111	0.142	CbGaD
Doxorubicin—Topoisomerase Inhibitors—Epirubicin—hematologic cancer	0.0102	0.0396	CiPCiCtD
Doxorubicin—Daunorubicin—Epirubicin—hematologic cancer	0.00704	0.0551	CrCrCtD
Doxorubicin—Idarubicin—Epirubicin—hematologic cancer	0.00704	0.0551	CrCrCtD
Doxorubicin—Valrubicin—Epirubicin—hematologic cancer	0.00704	0.0551	CrCrCtD
Doxorubicin—AURKA—Epirubicin—hematologic cancer	0.00548	0.0419	CbGbCtD
Doxorubicin—YWHAG—Epirubicin—hematologic cancer	0.00548	0.0419	CbGbCtD
Doxorubicin—DHCR7—Epirubicin—hematologic cancer	0.00548	0.0419	CbGbCtD
Doxorubicin—XDH—Procarbazine—hematologic cancer	0.00496	0.0379	CbGbCtD
Doxorubicin—POR—Daunorubicin—hematologic cancer	0.00463	0.0354	CbGbCtD
Doxorubicin—ABCB1—hematologic cancer	0.00463	0.0592	CbGaD
Doxorubicin—ABCC6—Daunorubicin—hematologic cancer	0.00425	0.0325	CbGbCtD
Doxorubicin—RALBP1—Vincristine—hematologic cancer	0.0037	0.0283	CbGbCtD
Doxorubicin—ABCC6—Teniposide—hematologic cancer	0.0037	0.0283	CbGbCtD
Doxorubicin—CYP1B1—Procarbazine—hematologic cancer	0.00329	0.0252	CbGbCtD
Doxorubicin—ABCC10—Daunorubicin—hematologic cancer	0.00325	0.0249	CbGbCtD
Doxorubicin—TOP2A—Idarubicin—hematologic cancer	0.0032	0.0245	CbGbCtD
Doxorubicin—ABCC10—Cytarabine—hematologic cancer	0.00287	0.0219	CbGbCtD
Doxorubicin—XDH—Daunorubicin—hematologic cancer	0.00266	0.0203	CbGbCtD
Doxorubicin—NOS2—Dexamethasone—hematologic cancer	0.00233	0.0179	CbGbCtD
Doxorubicin—TOP2A—Daunorubicin—hematologic cancer	0.00226	0.0173	CbGbCtD
Doxorubicin—XDH—Mercaptopurine—hematologic cancer	0.00206	0.0157	CbGbCtD
Doxorubicin—NQO1—Cisplatin—hematologic cancer	0.00198	0.0152	CbGbCtD
Doxorubicin—TOP2A—Teniposide—hematologic cancer	0.00197	0.015	CbGbCtD
Doxorubicin—ABCC6—Vinblastine—hematologic cancer	0.00181	0.0138	CbGbCtD
Doxorubicin—ABCC1—Idarubicin—hematologic cancer	0.00177	0.0136	CbGbCtD
Doxorubicin—ABCB11—Daunorubicin—hematologic cancer	0.00177	0.0135	CbGbCtD
Doxorubicin—CYP1B1—Daunorubicin—hematologic cancer	0.00177	0.0135	CbGbCtD
Doxorubicin—ABCC10—Gemcitabine—hematologic cancer	0.00174	0.0133	CbGbCtD
Doxorubicin—ABCC6—Cisplatin—hematologic cancer	0.00166	0.0127	CbGbCtD
Doxorubicin—ABCC6—Etoposide—hematologic cancer	0.00163	0.0125	CbGbCtD
Doxorubicin—ABCG2—Clofarabine—hematologic cancer	0.00143	0.011	CbGbCtD
Doxorubicin—TOP2A—Mitoxantrone—hematologic cancer	0.00138	0.0105	CbGbCtD
Doxorubicin—ABCC10—Vincristine—hematologic cancer	0.00136	0.0104	CbGbCtD
Doxorubicin—ABCC1—Daunorubicin—hematologic cancer	0.00125	0.0096	CbGbCtD
Doxorubicin—ABCC10—Etoposide—hematologic cancer	0.00125	0.00953	CbGbCtD
Doxorubicin—TOP2A—Epirubicin—hematologic cancer	0.00111	0.00852	CbGbCtD
Doxorubicin—CYP1B1—Dasatinib—hematologic cancer	0.00109	0.00831	CbGbCtD
Doxorubicin—CYP1B1—Mitoxantrone—hematologic cancer	0.00107	0.00821	CbGbCtD
Doxorubicin—XDH—Cisplatin—hematologic cancer	0.00104	0.00793	CbGbCtD
Doxorubicin—ABCC2—Daunorubicin—hematologic cancer	0.000929	0.00711	CbGbCtD
Doxorubicin—TOP2A—Etoposide—hematologic cancer	0.000868	0.00664	CbGbCtD
Doxorubicin—ABCC3—Vincristine—hematologic cancer	0.000855	0.00654	CbGbCtD
Doxorubicin—ABCG2—Daunorubicin—hematologic cancer	0.00084	0.00642	CbGbCtD
Doxorubicin—CYP2B6—Thiotepa—hematologic cancer	0.000835	0.00639	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—hematologic cancer	0.000823	0.00629	CbGbCtD
Doxorubicin—ABCC3—Cisplatin—hematologic cancer	0.000797	0.0061	CbGbCtD
Doxorubicin—ABCC3—Etoposide—hematologic cancer	0.000783	0.00599	CbGbCtD
Doxorubicin—ABCC1—Mitoxantrone—hematologic cancer	0.000763	0.00583	CbGbCtD
Doxorubicin—ABCB11—Vinblastine—hematologic cancer	0.000751	0.00575	CbGbCtD
Doxorubicin—ABCB11—Vincristine—hematologic cancer	0.000739	0.00565	CbGbCtD
Doxorubicin—ABCG2—Teniposide—hematologic cancer	0.00073	0.00558	CbGbCtD
Doxorubicin—ABCG2—Cladribine—hematologic cancer	0.0007	0.00535	CbGbCtD
Doxorubicin—ABCG2—Imatinib—hematologic cancer	0.000643	0.00492	CbGbCtD
Doxorubicin—ABCC1—Epirubicin—hematologic cancer	0.000617	0.00472	CbGbCtD
Doxorubicin—ABCC1—Irinotecan—hematologic cancer	0.0006	0.00459	CbGbCtD
Doxorubicin—ABCG2—Nilotinib—hematologic cancer	0.000585	0.00447	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—hematologic cancer	0.000557	0.00426	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—hematologic cancer	0.000557	0.00426	CbGbCtD
Doxorubicin—ABCC1—Vinblastine—hematologic cancer	0.000534	0.00408	CbGbCtD
Doxorubicin—ABCC1—Vincristine—hematologic cancer	0.000525	0.00401	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—hematologic cancer	0.000518	0.00396	CbGbCtD
Doxorubicin—ABCG2—Dasatinib—hematologic cancer	0.000517	0.00395	CbGbCtD
Doxorubicin—ABCB1—Lenalidomide—hematologic cancer	0.000517	0.00395	CbGbCtD
Doxorubicin—ABCG2—Mitoxantrone—hematologic cancer	0.00051	0.0039	CbGbCtD
Doxorubicin—ABCC1—Etoposide—hematologic cancer	0.000481	0.00368	CbGbCtD
Doxorubicin—CYP2B6—Ifosfamide—hematologic cancer	0.000474	0.00362	CbGbCtD
Doxorubicin—CYP2D6—Lomustine—hematologic cancer	0.000452	0.00346	CbGbCtD
Doxorubicin—ABCC2—Irinotecan—hematologic cancer	0.000444	0.0034	CbGbCtD
Doxorubicin—CYP2B6—Nilotinib—hematologic cancer	0.000411	0.00314	CbGbCtD
Doxorubicin—CYP2D6—Idarubicin—hematologic cancer	0.000403	0.00308	CbGbCtD
Doxorubicin—ABCG2—Irinotecan—hematologic cancer	0.000402	0.00307	CbGbCtD
Doxorubicin—ABCC2—Vinblastine—hematologic cancer	0.000395	0.00302	CbGbCtD
Doxorubicin—ABCC2—Vincristine—hematologic cancer	0.000388	0.00297	CbGbCtD
Doxorubicin—ABCC2—Cisplatin—hematologic cancer	0.000362	0.00277	CbGbCtD
Doxorubicin—ABCC2—Etoposide—hematologic cancer	0.000356	0.00272	CbGbCtD
Doxorubicin—ABCG2—Vincristine—hematologic cancer	0.000351	0.00269	CbGbCtD
Doxorubicin—CYP2D6—Hydroxyurea—hematologic cancer	0.000343	0.00262	CbGbCtD
Doxorubicin—ABCG2—Cisplatin—hematologic cancer	0.000328	0.00251	CbGbCtD
Doxorubicin—ABCG2—Etoposide—hematologic cancer	0.000322	0.00246	CbGbCtD
Doxorubicin—ABCB8—hematopoietic system—hematologic cancer	0.000322	0.0219	CbGeAlD
Doxorubicin—ABCC1—Methotrexate—hematologic cancer	0.000318	0.00243	CbGbCtD
Doxorubicin—SLC22A16—gonad—hematologic cancer	0.000315	0.0214	CbGeAlD
Doxorubicin—CYP3A4—Bexarotene—hematologic cancer	0.000309	0.00237	CbGbCtD
Doxorubicin—ABCB1—Daunorubicin—hematologic cancer	0.000303	0.00232	CbGbCtD
Doxorubicin—CYP2D6—Bortezomib—hematologic cancer	0.000298	0.00228	CbGbCtD
Doxorubicin—ABCB1—Alitretinoin—hematologic cancer	0.000297	0.00227	CbGbCtD
Doxorubicin—ABCC2—Dexamethasone—hematologic cancer	0.000293	0.00224	CbGbCtD
Doxorubicin—CYP3A4—Lomustine—hematologic cancer	0.000288	0.0022	CbGbCtD
Doxorubicin—CYP3A4—Busulfan—hematologic cancer	0.000288	0.0022	CbGbCtD
Doxorubicin—CYP2B6—Irinotecan—hematologic cancer	0.000283	0.00216	CbGbCtD
Doxorubicin—Daunorubicin—TOP2B—hematologic cancer	0.000281	0.375	CrCbGaD
Doxorubicin—SLC22A16—blood—hematologic cancer	0.000274	0.0186	CbGeAlD
Doxorubicin—SLC22A16—bone marrow—hematologic cancer	0.000265	0.018	CbGeAlD
Doxorubicin—ABCG2—Dexamethasone—hematologic cancer	0.000265	0.00202	CbGbCtD
Doxorubicin—CYP3A4—Thiotepa—hematologic cancer	0.000256	0.00196	CbGbCtD
Doxorubicin—ABCB8—gonad—hematologic cancer	0.000245	0.0166	CbGeAlD
Doxorubicin—AKR1A1—hematopoietic system—hematologic cancer	0.000239	0.0162	CbGeAlD
Doxorubicin—ABCC2—Methotrexate—hematologic cancer	0.000235	0.0018	CbGbCtD
Doxorubicin—ABCB1—Imatinib—hematologic cancer	0.000232	0.00177	CbGbCtD
Doxorubicin—CYP2B6—Cisplatin—hematologic cancer	0.00023	0.00176	CbGbCtD
Doxorubicin—SLC22A16—testis—hematologic cancer	0.000227	0.0154	CbGeAlD
Doxorubicin—CYP2D6—Imatinib—hematologic cancer	0.000219	0.00167	CbGbCtD
Doxorubicin—NDUFS7—hematopoietic system—hematologic cancer	0.000217	0.0148	CbGeAlD
Doxorubicin—ABCB8—blood—hematologic cancer	0.000213	0.0145	CbGeAlD
Doxorubicin—ABCG2—Methotrexate—hematologic cancer	0.000213	0.00163	CbGbCtD
Doxorubicin—ABCB1—Nilotinib—hematologic cancer	0.000211	0.00161	CbGbCtD
Doxorubicin—ABCB1—Vinorelbine—hematologic cancer	0.000209	0.0016	CbGbCtD
Doxorubicin—CBR3—blood—hematologic cancer	0.000205	0.0139	CbGeAlD
Doxorubicin—AURKA—hematopoietic system—hematologic cancer	0.000202	0.0137	CbGeAlD
Doxorubicin—CYP3A4—Methoxsalen—hematologic cancer	0.000199	0.00153	CbGbCtD
Doxorubicin—CYP2D6—Nilotinib—hematologic cancer	0.000199	0.00152	CbGbCtD
Doxorubicin—CYP2D6—Vinorelbine—hematologic cancer	0.000197	0.00151	CbGbCtD
Doxorubicin—CYP3A4—Bortezomib—hematologic cancer	0.00019	0.00145	CbGbCtD
Doxorubicin—ABCB8—lung—hematologic cancer	0.000187	0.0127	CbGeAlD
Doxorubicin—ABCB1—Dasatinib—hematologic cancer	0.000186	0.00142	CbGbCtD
Doxorubicin—CYP2B6—Dexamethasone—hematologic cancer	0.000186	0.00142	CbGbCtD
Doxorubicin—ABCB1—Mitoxantrone—hematologic cancer	0.000184	0.00141	CbGbCtD
Doxorubicin—AKR1A1—gonad—hematologic cancer	0.000182	0.0123	CbGeAlD
Doxorubicin—CYP3A4—Daunorubicin—hematologic cancer	0.000181	0.00139	CbGbCtD
Doxorubicin—NOS1—hematopoietic system—hematologic cancer	0.000181	0.0123	CbGeAlD
Doxorubicin—NDUFS2—hematopoietic system—hematologic cancer	0.00018	0.0122	CbGeAlD
Doxorubicin—CBR3—lung—hematologic cancer	0.00018	0.0122	CbGeAlD
Doxorubicin—Valrubicin—TOP2A—hematologic cancer	0.000179	0.239	CrCbGaD
Doxorubicin—NDUFS3—hematopoietic system—hematologic cancer	0.000178	0.0121	CbGeAlD
Doxorubicin—ABCB8—testis—hematologic cancer	0.000176	0.012	CbGeAlD
Doxorubicin—CBR3—testis—hematologic cancer	0.00017	0.0115	CbGeAlD
Doxorubicin—DHCR7—hematopoietic system—hematologic cancer	0.000169	0.0115	CbGeAlD
Doxorubicin—ABCC6—hematopoietic system—hematologic cancer	0.000165	0.0112	CbGeAlD
Doxorubicin—ABCB1—Betamethasone—hematologic cancer	0.000164	0.00125	CbGbCtD
Doxorubicin—ABCB1—Gemcitabine—hematologic cancer	0.000163	0.00124	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—hematologic cancer	0.000162	0.00124	CbGbCtD
Doxorubicin—CYP3A4—Cytarabine—hematologic cancer	0.00016	0.00122	CbGbCtD
Doxorubicin—AKR1A1—blood—hematologic cancer	0.000158	0.0108	CbGeAlD
Doxorubicin—CYP3A4—Teniposide—hematologic cancer	0.000158	0.00121	CbGbCtD
Doxorubicin—YWHAG—hematopoietic system—hematologic cancer	0.000155	0.0105	CbGeAlD
Doxorubicin—AURKA—gonad—hematologic cancer	0.000154	0.0104	CbGeAlD
Doxorubicin—AKR1A1—bone marrow—hematologic cancer	0.000153	0.0104	CbGeAlD
Doxorubicin—ABCB1—Prednisone—hematologic cancer	0.000153	0.00117	CbGbCtD
Doxorubicin—CYP3A4—Ifosfamide—hematologic cancer	0.000145	0.00111	CbGbCtD
Doxorubicin—ABCB1—Irinotecan—hematologic cancer	0.000145	0.00111	CbGbCtD
Doxorubicin—NDUFS7—blood—hematologic cancer	0.000144	0.00978	CbGeAlD
Doxorubicin—RALBP1—hematopoietic system—hematologic cancer	0.00014	0.00951	CbGeAlD
Doxorubicin—NDUFS7—bone marrow—hematologic cancer	0.000139	0.00946	CbGeAlD
Doxorubicin—CYP3A4—Imatinib—hematologic cancer	0.000139	0.00106	CbGbCtD
Doxorubicin—AKR1A1—lung—hematologic cancer	0.000139	0.00943	CbGeAlD
Doxorubicin—NOS1—gonad—hematologic cancer	0.000138	0.00936	CbGeAlD
Doxorubicin—NOS3—hematopoietic system—hematologic cancer	0.000138	0.00936	CbGeAlD
Doxorubicin—NDUFS2—gonad—hematologic cancer	0.000137	0.0093	CbGeAlD
Doxorubicin—NDUFS3—gonad—hematologic cancer	0.000135	0.00919	CbGeAlD
Doxorubicin—AURKA—blood—hematologic cancer	0.000134	0.00909	CbGeAlD
Doxorubicin—AKR1A1—testis—hematologic cancer	0.000131	0.0089	CbGeAlD
Doxorubicin—CYP3A4—Ruxolitinib—hematologic cancer	0.000131	0.001	CbGbCtD
Doxorubicin—AURKA—bone marrow—hematologic cancer	0.000129	0.0088	CbGeAlD
Doxorubicin—ABCB1—Vinblastine—hematologic cancer	0.000129	0.000985	CbGbCtD
Doxorubicin—DHCR7—gonad—hematologic cancer	0.000128	0.00873	CbGeAlD
Doxorubicin—ABCB8—lymph node—hematologic cancer	0.000128	0.00868	CbGeAlD
Doxorubicin—ABCB1—Vincristine—hematologic cancer	0.000127	0.000969	CbGbCtD
Doxorubicin—CYP3A4—Nilotinib—hematologic cancer	0.000126	0.000966	CbGbCtD
Doxorubicin—NDUFS7—lung—hematologic cancer	0.000126	0.00857	CbGeAlD
Doxorubicin—CYP3A4—Vinorelbine—hematologic cancer	0.000125	0.000958	CbGbCtD
Doxorubicin—CBR3—lymph node—hematologic cancer	0.000123	0.00836	CbGeAlD
Doxorubicin—CYP2D6—Vinblastine—hematologic cancer	0.000121	0.000928	CbGbCtD
Doxorubicin—NOS1—blood—hematologic cancer	0.00012	0.00815	CbGeAlD
Doxorubicin—NDUFS2—blood—hematologic cancer	0.000119	0.0081	CbGeAlD
Doxorubicin—NDUFS7—testis—hematologic cancer	0.000119	0.00809	CbGeAlD
Doxorubicin—ABCB1—Cisplatin—hematologic cancer	0.000118	0.000903	CbGbCtD
Doxorubicin—YWHAG—gonad—hematologic cancer	0.000118	0.00801	CbGeAlD
Doxorubicin—NDUFS3—blood—hematologic cancer	0.000118	0.008	CbGeAlD
Doxorubicin—AURKA—lung—hematologic cancer	0.000117	0.00797	CbGeAlD
Doxorubicin—ABCB1—Etoposide—hematologic cancer	0.000116	0.000888	CbGbCtD
Doxorubicin—NDUFS2—bone marrow—hematologic cancer	0.000115	0.00784	CbGeAlD
Doxorubicin—CYP3A4—Triamcinolone—hematologic cancer	0.000115	0.000876	CbGbCtD
Doxorubicin—NDUFS3—bone marrow—hematologic cancer	0.000114	0.00775	CbGeAlD
Doxorubicin—DHCR7—blood—hematologic cancer	0.000112	0.00761	CbGeAlD
Doxorubicin—CYP3A4—Dasatinib—hematologic cancer	0.000112	0.000854	CbGbCtD
Doxorubicin—AURKA—testis—hematologic cancer	0.000111	0.00752	CbGeAlD
Doxorubicin—CYP3A4—Mitoxantrone—hematologic cancer	0.00011	0.000843	CbGbCtD
Doxorubicin—ABCC6—blood—hematologic cancer	0.000109	0.00741	CbGeAlD
Doxorubicin—DHCR7—bone marrow—hematologic cancer	0.000108	0.00736	CbGeAlD
Doxorubicin—NOS1—lung—hematologic cancer	0.000105	0.00715	CbGeAlD
Doxorubicin—NQO1—hematopoietic system—hematologic cancer	0.000105	0.00711	CbGeAlD
Doxorubicin—NDUFS2—lung—hematologic cancer	0.000105	0.0071	CbGeAlD
Doxorubicin—NDUFS3—lung—hematologic cancer	0.000103	0.00702	CbGeAlD
Doxorubicin—Idarubicin—TOP2A—hematologic cancer	0.000103	0.137	CrCbGaD
Doxorubicin—YWHAG—blood—hematologic cancer	0.000103	0.00698	CbGeAlD
Doxorubicin—YWHAG—bone marrow—hematologic cancer	9.94e-05	0.00675	CbGeAlD
Doxorubicin—CBR1—gonad—hematologic cancer	9.94e-05	0.00675	CbGeAlD
Doxorubicin—NOS1—testis—hematologic cancer	9.93e-05	0.00675	CbGeAlD
Doxorubicin—NDUFS2—testis—hematologic cancer	9.87e-05	0.0067	CbGeAlD
Doxorubicin—CYP3A4—Betamethasone—hematologic cancer	9.83e-05	0.000752	CbGbCtD
Doxorubicin—DHCR7—lung—hematologic cancer	9.81e-05	0.00667	CbGeAlD
Doxorubicin—NDUFS3—testis—hematologic cancer	9.75e-05	0.00662	CbGeAlD
Doxorubicin—CYP3A4—Prednisolone—hematologic cancer	9.7e-05	0.000742	CbGbCtD
Doxorubicin—ABCC6—lung—hematologic cancer	9.56e-05	0.0065	CbGeAlD
Doxorubicin—ABCB1—Dexamethasone—hematologic cancer	9.54e-05	0.00073	CbGbCtD
Doxorubicin—AKR1A1—lymph node—hematologic cancer	9.5e-05	0.00645	CbGeAlD
Doxorubicin—ABCC3—hematopoietic system—hematologic cancer	9.4e-05	0.00639	CbGeAlD
Doxorubicin—ABCC10—hematopoietic system—hematologic cancer	9.35e-05	0.00635	CbGeAlD
Doxorubicin—RALBP1—blood—hematologic cancer	9.28e-05	0.0063	CbGeAlD
Doxorubicin—DHCR7—testis—hematologic cancer	9.26e-05	0.00629	CbGeAlD
Doxorubicin—CYP3A4—Prednisone—hematologic cancer	9.16e-05	0.0007	CbGbCtD
Doxorubicin—NOS3—blood—hematologic cancer	9.13e-05	0.0062	CbGeAlD
Doxorubicin—YWHAG—lung—hematologic cancer	9.01e-05	0.00612	CbGeAlD
Doxorubicin—CYP2D6—Dexamethasone—hematologic cancer	8.99e-05	0.000688	CbGbCtD
Doxorubicin—RALBP1—bone marrow—hematologic cancer	8.98e-05	0.0061	CbGeAlD
Doxorubicin—CYP3A4—Irinotecan—hematologic cancer	8.68e-05	0.000664	CbGbCtD
Doxorubicin—CBR1—blood—hematologic cancer	8.66e-05	0.00588	CbGeAlD
Doxorubicin—NDUFS7—lymph node—hematologic cancer	8.63e-05	0.00586	CbGeAlD
Doxorubicin—AKR1C3—blood—hematologic cancer	8.55e-05	0.00581	CbGeAlD
Doxorubicin—YWHAG—testis—hematologic cancer	8.5e-05	0.00577	CbGeAlD
Doxorubicin—CBR1—bone marrow—hematologic cancer	8.38e-05	0.00569	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—hematologic cancer	8.28e-05	0.00562	CbGeAlD
Doxorubicin—RALBP1—lung—hematologic cancer	8.13e-05	0.00552	CbGeAlD
Doxorubicin—ABCB11—testis—hematologic cancer	8.09e-05	0.0055	CbGeAlD
Doxorubicin—AURKA—lymph node—hematologic cancer	8.02e-05	0.00545	CbGeAlD
Doxorubicin—NOS3—lung—hematologic cancer	8e-05	0.00543	CbGeAlD
Doxorubicin—POR—blood—hematologic cancer	7.81e-05	0.00531	CbGeAlD
Doxorubicin—Epirubicin—TOP2A—hematologic cancer	7.79e-05	0.104	CrCbGaD
Doxorubicin—CYP3A4—Vinblastine—hematologic cancer	7.72e-05	0.00059	CbGbCtD
Doxorubicin—RALBP1—testis—hematologic cancer	7.67e-05	0.00521	CbGeAlD
Doxorubicin—ABCB1—Methotrexate—hematologic cancer	7.67e-05	0.000586	CbGbCtD
Doxorubicin—CBR1—lung—hematologic cancer	7.59e-05	0.00516	CbGeAlD
Doxorubicin—CYP3A4—Vincristine—hematologic cancer	7.59e-05	0.00058	CbGbCtD
Doxorubicin—POR—bone marrow—hematologic cancer	7.56e-05	0.00513	CbGeAlD
Doxorubicin—NOS3—testis—hematologic cancer	7.55e-05	0.00513	CbGeAlD
Doxorubicin—AKR1C3—lung—hematologic cancer	7.5e-05	0.00509	CbGeAlD
Doxorubicin—CYP1B1—hematopoietic system—hematologic cancer	7.36e-05	0.005	CbGeAlD
Doxorubicin—TOP2A—blood—hematologic cancer	7.28e-05	0.00495	CbGeAlD
Doxorubicin—CBR1—testis—hematologic cancer	7.16e-05	0.00487	CbGeAlD
Doxorubicin—NDUFS2—lymph node—hematologic cancer	7.15e-05	0.00486	CbGeAlD
Doxorubicin—ABCC10—gonad—hematologic cancer	7.11e-05	0.00483	CbGeAlD
Doxorubicin—AKR1C3—testis—hematologic cancer	7.07e-05	0.00481	CbGeAlD
Doxorubicin—NDUFS3—lymph node—hematologic cancer	7.06e-05	0.0048	CbGeAlD
Doxorubicin—TOP2A—bone marrow—hematologic cancer	7.04e-05	0.00478	CbGeAlD
Doxorubicin—CYP3A4—Etoposide—hematologic cancer	6.95e-05	0.000532	CbGbCtD
Doxorubicin—POR—lung—hematologic cancer	6.85e-05	0.00465	CbGeAlD
Doxorubicin—DHCR7—lymph node—hematologic cancer	6.71e-05	0.00456	CbGeAlD
Doxorubicin—POR—testis—hematologic cancer	6.46e-05	0.00439	CbGeAlD
Doxorubicin—TOP2A—lung—hematologic cancer	6.38e-05	0.00434	CbGeAlD
Doxorubicin—ABCC3—blood—hematologic cancer	6.23e-05	0.00423	CbGeAlD
Doxorubicin—ABCC10—blood—hematologic cancer	6.2e-05	0.00421	CbGeAlD
Doxorubicin—YWHAG—lymph node—hematologic cancer	6.16e-05	0.00418	CbGeAlD
Doxorubicin—NQO1—lung—hematologic cancer	6.08e-05	0.00413	CbGeAlD
Doxorubicin—TOP2A—testis—hematologic cancer	6.02e-05	0.00409	CbGeAlD
Doxorubicin—ABCC10—bone marrow—hematologic cancer	6e-05	0.00407	CbGeAlD
Doxorubicin—NQO1—testis—hematologic cancer	5.74e-05	0.0039	CbGeAlD
Doxorubicin—CYP3A4—Dexamethasone—hematologic cancer	5.72e-05	0.000437	CbGbCtD
Doxorubicin—CYP1B1—gonad—hematologic cancer	5.59e-05	0.0038	CbGeAlD
Doxorubicin—RALBP1—lymph node—hematologic cancer	5.56e-05	0.00378	CbGeAlD
Doxorubicin—Daunorubicin—TOP2A—hematologic cancer	5.51e-05	0.0736	CrCbGaD
Doxorubicin—NOS3—lymph node—hematologic cancer	5.47e-05	0.00372	CbGeAlD
Doxorubicin—ABCC3—lung—hematologic cancer	5.46e-05	0.00371	CbGeAlD
Doxorubicin—ABCC10—lung—hematologic cancer	5.43e-05	0.00369	CbGeAlD
Doxorubicin—CBR1—lymph node—hematologic cancer	5.19e-05	0.00353	CbGeAlD
Doxorubicin—ABCC3—testis—hematologic cancer	5.15e-05	0.0035	CbGeAlD
Doxorubicin—AKR1C3—lymph node—hematologic cancer	5.13e-05	0.00348	CbGeAlD
Doxorubicin—ABCC10—testis—hematologic cancer	5.13e-05	0.00348	CbGeAlD
Doxorubicin—CYP2B6—hematopoietic system—hematologic cancer	5.05e-05	0.00343	CbGeAlD
Doxorubicin—ABCC2—blood—hematologic cancer	4.98e-05	0.00338	CbGeAlD
Doxorubicin—CYP1B1—blood—hematologic cancer	4.87e-05	0.00331	CbGeAlD
Doxorubicin—POR—lymph node—hematologic cancer	4.68e-05	0.00318	CbGeAlD
Doxorubicin—ABCC1—blood—hematologic cancer	4.38e-05	0.00298	CbGeAlD
Doxorubicin—TOP2A—lymph node—hematologic cancer	4.36e-05	0.00296	CbGeAlD
Doxorubicin—CYP1B1—lung—hematologic cancer	4.27e-05	0.0029	CbGeAlD
Doxorubicin—NQO1—lymph node—hematologic cancer	4.16e-05	0.00283	CbGeAlD
Doxorubicin—ABCC2—testis—hematologic cancer	4.12e-05	0.0028	CbGeAlD
Doxorubicin—CYP1B1—testis—hematologic cancer	4.03e-05	0.00274	CbGeAlD
Doxorubicin—ABCC1—lung—hematologic cancer	3.84e-05	0.00261	CbGeAlD
Doxorubicin—CYP2B6—gonad—hematologic cancer	3.84e-05	0.00261	CbGeAlD
Doxorubicin—CYP3A4—hematopoietic system—hematologic cancer	3.82e-05	0.00259	CbGeAlD
Doxorubicin—Daunorubicin—ABCG2—hematologic cancer	3.77e-05	0.0503	CrCbGaD
Doxorubicin—CYP2D6—hematopoietic system—hematologic cancer	3.75e-05	0.00255	CbGeAlD
Doxorubicin—ABCC3—lymph node—hematologic cancer	3.73e-05	0.00254	CbGeAlD
Doxorubicin—ABCC10—lymph node—hematologic cancer	3.72e-05	0.00252	CbGeAlD
Doxorubicin—ABCG2—blood—hematologic cancer	3.63e-05	0.00247	CbGeAlD
Doxorubicin—ABCC1—testis—hematologic cancer	3.63e-05	0.00246	CbGeAlD
Doxorubicin—ABCG2—bone marrow—hematologic cancer	3.51e-05	0.00239	CbGeAlD
Doxorubicin—CYP2B6—blood—hematologic cancer	3.35e-05	0.00227	CbGeAlD
Doxorubicin—ABCG2—lung—hematologic cancer	3.18e-05	0.00216	CbGeAlD
Doxorubicin—ABCG2—testis—hematologic cancer	3e-05	0.00204	CbGeAlD
Doxorubicin—ABCC2—lymph node—hematologic cancer	2.98e-05	0.00203	CbGeAlD
Doxorubicin—CYP2B6—lung—hematologic cancer	2.93e-05	0.00199	CbGeAlD
Doxorubicin—CYP1B1—lymph node—hematologic cancer	2.92e-05	0.00198	CbGeAlD
Doxorubicin—CYP2B6—testis—hematologic cancer	2.77e-05	0.00188	CbGeAlD
Doxorubicin—ABCB1—hematopoietic system—hematologic cancer	2.7e-05	0.00183	CbGeAlD
Doxorubicin—AURKA—Chlorambucil—Melphalan—hematologic cancer	2.69e-05	0.0364	CbGdCrCtD
Doxorubicin—ABCC1—lymph node—hematologic cancer	2.63e-05	0.00179	CbGeAlD
Doxorubicin—CYP3A4—blood—hematologic cancer	2.53e-05	0.00172	CbGeAlD
Doxorubicin—CYP2D6—blood—hematologic cancer	2.49e-05	0.00169	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Teniposide—hematologic cancer	2.48e-05	0.0336	CbGdCrCtD
Doxorubicin—ABCG2—lymph node—hematologic cancer	2.18e-05	0.00148	CbGeAlD
Doxorubicin—AKR1C3—Podofilox—Teniposide—hematologic cancer	2.17e-05	0.0293	CbGdCrCtD
Doxorubicin—CYP2D6—testis—hematologic cancer	2.06e-05	0.0014	CbGeAlD
Doxorubicin—ABCB1—gonad—hematologic cancer	2.05e-05	0.00139	CbGeAlD
Doxorubicin—CBR3—Epirubicin—Daunorubicin—hematologic cancer	1.99e-05	0.0269	CbGdCrCtD
Doxorubicin—CBR3—Idarubicin—Daunorubicin—hematologic cancer	1.99e-05	0.0269	CbGdCrCtD
Doxorubicin—ABCB1—blood—hematologic cancer	1.79e-05	0.00122	CbGeAlD
Doxorubicin—ABCB1—bone marrow—hematologic cancer	1.73e-05	0.00118	CbGeAlD
Doxorubicin—NQO1—Vincristine—Vinorelbine—hematologic cancer	1.73e-05	0.0234	CbGdCrCtD
Doxorubicin—ABCB1—lung—hematologic cancer	1.57e-05	0.00107	CbGeAlD
Doxorubicin—Daunorubicin—ABCB1—hematologic cancer	1.57e-05	0.0209	CrCbGaD
Doxorubicin—AURKA—Topotecan—Irinotecan—hematologic cancer	1.55e-05	0.021	CbGdCrCtD
Doxorubicin—AURKA—Etoposide—Teniposide—hematologic cancer	1.54e-05	0.0209	CbGdCrCtD
Doxorubicin—CBR3—Daunorubicin—Idarubicin—hematologic cancer	1.51e-05	0.0204	CbGdCrCtD
Doxorubicin—CBR3—Epirubicin—Idarubicin—hematologic cancer	1.51e-05	0.0204	CbGdCrCtD
Doxorubicin—ABCB1—testis—hematologic cancer	1.48e-05	0.00101	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Etoposide—hematologic cancer	1.47e-05	0.02	CbGdCrCtD
Doxorubicin—NQO1—Vincristine—Vinblastine—hematologic cancer	1.38e-05	0.0187	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinorelbine—hematologic cancer	1.38e-05	0.0187	CbGdCrCtD
Doxorubicin—CBR3—Teniposide—Etoposide—hematologic cancer	1.33e-05	0.018	CbGdCrCtD
Doxorubicin—AKR1C3—Podofilox—Etoposide—hematologic cancer	1.29e-05	0.0174	CbGdCrCtD
Doxorubicin—AKR1C3—Vinblastine—Vinorelbine—hematologic cancer	1.11e-05	0.015	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinblastine—hematologic cancer	1.1e-05	0.0149	CbGdCrCtD
Doxorubicin—ABCB1—lymph node—hematologic cancer	1.07e-05	0.000729	CbGeAlD
Doxorubicin—AURKA—Floxuridine—Pentostatin—hematologic cancer	1.07e-05	0.0145	CbGdCrCtD
Doxorubicin—TOP2A—Nilotinib—Imatinib—hematologic cancer	1.07e-05	0.0145	CbGdCrCtD
Doxorubicin—CBR1—Vincristine—Vinorelbine—hematologic cancer	1.05e-05	0.0143	CbGdCrCtD
Doxorubicin—AURKA—Idarubicin—Daunorubicin—hematologic cancer	1.05e-05	0.0142	CbGdCrCtD
Doxorubicin—AURKA—Epirubicin—Daunorubicin—hematologic cancer	1.05e-05	0.0142	CbGdCrCtD
Doxorubicin—AURKA—Menadione—Thalidomide—hematologic cancer	8.91e-06	0.0121	CbGdCrCtD
Doxorubicin—AKR1C3—Vinblastine—Vincristine—hematologic cancer	8.87e-06	0.012	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Pentostatin—hematologic cancer	8.66e-06	0.0117	CbGdCrCtD
Doxorubicin—CBR1—Vincristine—Vinblastine—hematologic cancer	8.42e-06	0.0114	CbGdCrCtD
Doxorubicin—CBR3—Gemcitabine—Cytarabine—hematologic cancer	8.13e-06	0.011	CbGdCrCtD
Doxorubicin—AURKA—Cladribine—Pentostatin—hematologic cancer	8.1e-06	0.011	CbGdCrCtD
Doxorubicin—AURKA—Daunorubicin—Idarubicin—hematologic cancer	7.95e-06	0.0108	CbGdCrCtD
Doxorubicin—AURKA—Epirubicin—Idarubicin—hematologic cancer	7.95e-06	0.0108	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Clofarabine—hematologic cancer	7.72e-06	0.0105	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Nelarabine—hematologic cancer	7.26e-06	0.00983	CbGdCrCtD
Doxorubicin—AURKA—Cladribine—Clofarabine—hematologic cancer	7.22e-06	0.00977	CbGdCrCtD
Doxorubicin—AURKA—Teniposide—Etoposide—hematologic cancer	7e-06	0.00947	CbGdCrCtD
Doxorubicin—CBR3—Idarubicin—Epirubicin—hematologic cancer	6.92e-06	0.00937	CbGdCrCtD
Doxorubicin—CBR3—Daunorubicin—Epirubicin—hematologic cancer	6.92e-06	0.00937	CbGdCrCtD
Doxorubicin—AURKA—Cladribine—Nelarabine—hematologic cancer	6.79e-06	0.00918	CbGdCrCtD
Doxorubicin—AURKA—Floxuridine—Cladribine—hematologic cancer	6.44e-06	0.00871	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Pentostatin—hematologic cancer	6.42e-06	0.00869	CbGdCrCtD
Doxorubicin—AURKA—Clofarabine—Nelarabine—hematologic cancer	6.27e-06	0.00849	CbGdCrCtD
Doxorubicin—TOP2A—Topotecan—Irinotecan—hematologic cancer	5.93e-06	0.00803	CbGdCrCtD
Doxorubicin—TOP2A—Etoposide—Teniposide—hematologic cancer	5.89e-06	0.00798	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Clofarabine—hematologic cancer	5.72e-06	0.00775	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Clofarabine—hematologic cancer	5.68e-06	0.00768	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Fludarabine—hematologic cancer	5.67e-06	0.00767	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Nelarabine—hematologic cancer	5.38e-06	0.00728	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Gemcitabine—hematologic cancer	5.35e-06	0.00725	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Cytarabine—hematologic cancer	5.35e-06	0.00725	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Nelarabine—hematologic cancer	5.34e-06	0.00722	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	5.3e-06	0.00718	CbGdCrCtD
Doxorubicin—AURKA—Cladribine—Fludarabine—hematologic cancer	5.3e-06	0.00717	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Cladribine—hematologic cancer	5.22e-06	0.00706	CbGdCrCtD
Doxorubicin—AURKA—Clofarabine—Fludarabine—hematologic cancer	4.9e-06	0.00663	CbGdCrCtD
Doxorubicin—AURKA—Clofarabine—Cytarabine—hematologic cancer	4.62e-06	0.00626	CbGdCrCtD
Doxorubicin—AURKA—Clofarabine—Cladribine—hematologic cancer	4.51e-06	0.0061	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Teniposide—hematologic cancer	4.49e-06	0.00608	CbGdCrCtD
Doxorubicin—AURKA—Gemcitabine—Cytarabine—hematologic cancer	4.28e-06	0.0058	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vinblastine—hematologic cancer	4.24e-06	0.00574	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vincristine—hematologic cancer	4.24e-06	0.00574	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Fludarabine—hematologic cancer	4.2e-06	0.00569	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Fludarabine—hematologic cancer	4.17e-06	0.00564	CbGdCrCtD
Doxorubicin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	4.09e-06	0.00553	CbGdCrCtD
Doxorubicin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	4.01e-06	0.00542	CbGdCrCtD
Doxorubicin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	4.01e-06	0.00542	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Gemcitabine—hematologic cancer	3.97e-06	0.00537	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Cytarabine—hematologic cancer	3.97e-06	0.00537	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Gemcitabine—hematologic cancer	3.93e-06	0.00533	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—hematologic cancer	3.9e-06	0.00527	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—hematologic cancer	3.9e-06	0.00527	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Cladribine—hematologic cancer	3.87e-06	0.00523	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—hematologic cancer	3.81e-06	0.00515	CbGdCrCtD
Doxorubicin—AURKA—Daunorubicin—Epirubicin—hematologic cancer	3.65e-06	0.00494	CbGdCrCtD
Doxorubicin—AURKA—Idarubicin—Epirubicin—hematologic cancer	3.65e-06	0.00494	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisone—hematologic cancer	3.61e-06	0.00489	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—hematologic cancer	3.53e-06	0.00477	CbGdCrCtD
Doxorubicin—TOP2A—Menadione—Thalidomide—hematologic cancer	3.41e-06	0.00461	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—hematologic cancer	3.22e-06	0.00436	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—hematologic cancer	3.22e-06	0.00436	CbGdCrCtD
Doxorubicin—TOP2A—Cladribine—Pentostatin—hematologic cancer	3.09e-06	0.00419	CbGdCrCtD
Doxorubicin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	3.04e-06	0.00411	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	3.04e-06	0.00411	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisone—hematologic cancer	2.99e-06	0.00404	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	2.96e-06	0.00401	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—hematologic cancer	2.96e-06	0.00401	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—hematologic cancer	2.91e-06	0.00394	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	2.89e-06	0.00391	CbGdCrCtD
Doxorubicin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	2.86e-06	0.00387	CbGdCrCtD
Doxorubicin—TOP2A—Cladribine—Clofarabine—hematologic cancer	2.76e-06	0.00373	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—hematologic cancer	2.68e-06	0.00363	CbGdCrCtD
Doxorubicin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	2.67e-06	0.00362	CbGdCrCtD
Doxorubicin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	2.67e-06	0.00362	CbGdCrCtD
Doxorubicin—TOP2A—Teniposide—Etoposide—hematologic cancer	2.67e-06	0.00362	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Etoposide—hematologic cancer	2.67e-06	0.00362	CbGdCrCtD
Doxorubicin—TOP2A—Cladribine—Nelarabine—hematologic cancer	2.59e-06	0.00351	CbGdCrCtD
Doxorubicin—TOP2A—Floxuridine—Cladribine—hematologic cancer	2.46e-06	0.00333	CbGdCrCtD
Doxorubicin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	2.4e-06	0.00324	CbGdCrCtD
Doxorubicin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	2.3e-06	0.00311	CbGdCrCtD
Doxorubicin—TOP2A—Vincristine—Vinblastine—hematologic cancer	2.29e-06	0.0031	CbGdCrCtD
Doxorubicin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	2.17e-06	0.00294	CbGdCrCtD
Doxorubicin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	2.04e-06	0.00276	CbGdCrCtD
Doxorubicin—TOP2A—Cladribine—Fludarabine—hematologic cancer	2.02e-06	0.00274	CbGdCrCtD
Doxorubicin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	1.87e-06	0.00253	CbGdCrCtD
Doxorubicin—TOP2A—Vinblastine—Vincristine—hematologic cancer	1.84e-06	0.00249	CbGdCrCtD
Doxorubicin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	1.77e-06	0.00239	CbGdCrCtD
Doxorubicin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	1.74e-06	0.00236	CbGdCrCtD
Doxorubicin—TOP2A—Clofarabine—Cladribine—hematologic cancer	1.72e-06	0.00233	CbGdCrCtD
Doxorubicin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	1.64e-06	0.00221	CbGdCrCtD
Doxorubicin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	1.59e-06	0.00215	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—hematologic cancer	1.59e-06	0.00215	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—hematologic cancer	1.59e-06	0.00215	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—hematologic cancer	1.56e-06	0.00211	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—hematologic cancer	1.56e-06	0.00211	CbGdCrCtD
Doxorubicin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	1.55e-06	0.0021	CbGdCrCtD
Doxorubicin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	1.5e-06	0.00203	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisone—hematologic cancer	1.48e-06	0.002	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—hematologic cancer	1.48e-06	0.002	CbGdCrCtD
Doxorubicin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	1.46e-06	0.00198	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—hematologic cancer	1.44e-06	0.00195	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—hematologic cancer	1.44e-06	0.00195	CbGdCrCtD
Doxorubicin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	1.39e-06	0.00189	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	1.39e-06	0.00189	CbGdCrCtD
Doxorubicin—Myalgia—Prednisone—hematologic cancer	1.23e-06	2.67e-05	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—hematologic cancer	1.23e-06	2.67e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—hematologic cancer	1.23e-06	2.67e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Cisplatin—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Erythema multiforme—Epirubicin—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Vomiting—Gemcitabine—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—hematologic cancer	1.22e-06	2.66e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.22e-06	2.65e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—hematologic cancer	1.21e-06	2.64e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—hematologic cancer	1.21e-06	2.64e-05	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—hematologic cancer	1.21e-06	2.63e-05	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—hematologic cancer	1.21e-06	2.63e-05	CcSEcCtD
Doxorubicin—Rash—Gemcitabine—hematologic cancer	1.21e-06	2.63e-05	CcSEcCtD
Doxorubicin—Dermatitis—Gemcitabine—hematologic cancer	1.21e-06	2.63e-05	CcSEcCtD
Doxorubicin—Eye disorder—Epirubicin—hematologic cancer	1.21e-06	2.63e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Etoposide—hematologic cancer	1.21e-06	2.63e-05	CcSEcCtD
Doxorubicin—Tinnitus—Epirubicin—hematologic cancer	1.21e-06	2.62e-05	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—hematologic cancer	1.2e-06	2.62e-05	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—hematologic cancer	1.2e-06	2.62e-05	CcSEcCtD
Doxorubicin—Headache—Gemcitabine—hematologic cancer	1.2e-06	2.62e-05	CcSEcCtD
Doxorubicin—Nausea—Vincristine—hematologic cancer	1.2e-06	2.62e-05	CcSEcCtD
Doxorubicin—Cardiac disorder—Epirubicin—hematologic cancer	1.2e-06	2.61e-05	CcSEcCtD
Doxorubicin—Flushing—Epirubicin—hematologic cancer	1.2e-06	2.61e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisolone—hematologic cancer	1.19e-06	2.59e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Dexamethasone—hematologic cancer	1.19e-06	2.58e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Betamethasone—hematologic cancer	1.19e-06	2.58e-05	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—hematologic cancer	1.18e-06	2.57e-05	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—hematologic cancer	1.18e-06	2.56e-05	CcSEcCtD
Doxorubicin—Asthenia—Etoposide—hematologic cancer	1.18e-06	2.56e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—hematologic cancer	1.18e-06	2.56e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—hematologic cancer	1.18e-06	2.56e-05	CcSEcCtD
Doxorubicin—Oedema—Prednisone—hematologic cancer	1.18e-06	2.56e-05	CcSEcCtD
Doxorubicin—Angiopathy—Epirubicin—hematologic cancer	1.17e-06	2.55e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—hematologic cancer	1.17e-06	2.55e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—hematologic cancer	1.17e-06	2.55e-05	CcSEcCtD
Doxorubicin—Nausea—Mitoxantrone—hematologic cancer	1.17e-06	2.55e-05	CcSEcCtD
Doxorubicin—Nausea—Irinotecan—hematologic cancer	1.17e-06	2.55e-05	CcSEcCtD
Doxorubicin—Immune system disorder—Epirubicin—hematologic cancer	1.17e-06	2.54e-05	CcSEcCtD
Doxorubicin—Infection—Prednisone—hematologic cancer	1.17e-06	2.54e-05	CcSEcCtD
Doxorubicin—Mediastinal disorder—Epirubicin—hematologic cancer	1.17e-06	2.54e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.17e-06	2.53e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.17e-06	2.53e-05	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—hematologic cancer	1.16e-06	2.53e-05	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—hematologic cancer	1.16e-06	2.53e-05	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—hematologic cancer	1.16e-06	2.53e-05	CcSEcCtD
Doxorubicin—Chills—Epirubicin—hematologic cancer	1.16e-06	2.53e-05	CcSEcCtD
Doxorubicin—Pruritus—Etoposide—hematologic cancer	1.16e-06	2.52e-05	CcSEcCtD
Doxorubicin—Shock—Prednisone—hematologic cancer	1.16e-06	2.52e-05	CcSEcCtD
Doxorubicin—Arrhythmia—Epirubicin—hematologic cancer	1.16e-06	2.51e-05	CcSEcCtD
Doxorubicin—Pain—Betamethasone—hematologic cancer	1.15e-06	2.51e-05	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—hematologic cancer	1.15e-06	2.51e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—hematologic cancer	1.15e-06	2.51e-05	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—hematologic cancer	1.15e-06	2.5e-05	CcSEcCtD
Doxorubicin—Alopecia—Epirubicin—hematologic cancer	1.14e-06	2.49e-05	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—hematologic cancer	1.14e-06	2.48e-05	CcSEcCtD
Doxorubicin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	1.14e-06	0.00154	CbGdCrCtD
Doxorubicin—Nausea—Gemcitabine—hematologic cancer	1.14e-06	2.48e-05	CcSEcCtD
Doxorubicin—Vomiting—Cisplatin—hematologic cancer	1.14e-06	2.48e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—hematologic cancer	1.14e-06	2.47e-05	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—hematologic cancer	1.13e-06	2.47e-05	CcSEcCtD
Doxorubicin—Mental disorder—Epirubicin—hematologic cancer	1.13e-06	2.47e-05	CcSEcCtD
Doxorubicin—Rash—Cisplatin—hematologic cancer	1.13e-06	2.46e-05	CcSEcCtD
Doxorubicin—Dermatitis—Cisplatin—hematologic cancer	1.13e-06	2.45e-05	CcSEcCtD
Doxorubicin—Malnutrition—Epirubicin—hematologic cancer	1.13e-06	2.45e-05	CcSEcCtD
Doxorubicin—Erythema—Epirubicin—hematologic cancer	1.13e-06	2.45e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Etoposide—hematologic cancer	1.12e-06	2.44e-05	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—hematologic cancer	1.12e-06	2.44e-05	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—hematologic cancer	1.12e-06	2.43e-05	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—hematologic cancer	1.11e-06	2.42e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—hematologic cancer	1.11e-06	2.42e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—hematologic cancer	1.11e-06	2.42e-05	CcSEcCtD
Doxorubicin—Flatulence—Epirubicin—hematologic cancer	1.11e-06	2.41e-05	CcSEcCtD
Doxorubicin—Tension—Epirubicin—hematologic cancer	1.11e-06	2.4e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.1e-06	2.4e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.1e-06	2.4e-05	CcSEcCtD
Doxorubicin—Dysgeusia—Epirubicin—hematologic cancer	1.1e-06	2.4e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Triamcinolone—hematologic cancer	1.1e-06	2.38e-05	CcSEcCtD
Doxorubicin—Nervousness—Epirubicin—hematologic cancer	1.09e-06	2.38e-05	CcSEcCtD
Doxorubicin—Back pain—Epirubicin—hematologic cancer	1.09e-06	2.37e-05	CcSEcCtD
Doxorubicin—Malaise—Methotrexate—hematologic cancer	1.09e-06	2.36e-05	CcSEcCtD
Doxorubicin—Dizziness—Etoposide—hematologic cancer	1.08e-06	2.36e-05	CcSEcCtD
Doxorubicin—Muscle spasms—Epirubicin—hematologic cancer	1.08e-06	2.36e-05	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—hematologic cancer	1.08e-06	2.35e-05	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—hematologic cancer	1.08e-06	2.34e-05	CcSEcCtD
Doxorubicin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	1.08e-06	0.00146	CbGdCrCtD
Doxorubicin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	1.08e-06	0.00146	CbGdCrCtD
Doxorubicin—Urticaria—Dexamethasone—hematologic cancer	1.07e-06	2.33e-05	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—hematologic cancer	1.07e-06	2.33e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.07e-06	2.33e-05	CcSEcCtD
Doxorubicin—Dizziness—Prednisolone—hematologic cancer	1.07e-06	2.33e-05	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—hematologic cancer	1.07e-06	2.32e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—hematologic cancer	1.07e-06	2.32e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—hematologic cancer	1.07e-06	2.32e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—hematologic cancer	1.07e-06	2.32e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—hematologic cancer	1.07e-06	2.32e-05	CcSEcCtD
Doxorubicin—Nausea—Cisplatin—hematologic cancer	1.06e-06	2.31e-05	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—hematologic cancer	1.06e-06	2.31e-05	CcSEcCtD
Doxorubicin—Vision blurred—Epirubicin—hematologic cancer	1.06e-06	2.31e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—hematologic cancer	1.06e-06	2.3e-05	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—hematologic cancer	1.05e-06	2.29e-05	CcSEcCtD
Doxorubicin—Cough—Methotrexate—hematologic cancer	1.05e-06	2.28e-05	CcSEcCtD
Doxorubicin—TOP2A—Azacitidine—Cladribine—hematologic cancer	1.05e-06	0.00142	CbGdCrCtD
Doxorubicin—Ill-defined disorder—Epirubicin—hematologic cancer	1.05e-06	2.27e-05	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—hematologic cancer	1.04e-06	2.27e-05	CcSEcCtD
Doxorubicin—Vomiting—Etoposide—hematologic cancer	1.04e-06	2.27e-05	CcSEcCtD
Doxorubicin—Anaemia—Epirubicin—hematologic cancer	1.04e-06	2.26e-05	CcSEcCtD
Doxorubicin—Agitation—Epirubicin—hematologic cancer	1.04e-06	2.25e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—hematologic cancer	1.03e-06	2.25e-05	CcSEcCtD
Doxorubicin—Rash—Etoposide—hematologic cancer	1.03e-06	2.25e-05	CcSEcCtD
Doxorubicin—Dermatitis—Etoposide—hematologic cancer	1.03e-06	2.25e-05	CcSEcCtD
Doxorubicin—Headache—Etoposide—hematologic cancer	1.03e-06	2.23e-05	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—hematologic cancer	1.02e-06	2.23e-05	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—hematologic cancer	1.02e-06	2.23e-05	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—hematologic cancer	1.02e-06	2.23e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—hematologic cancer	1.02e-06	2.22e-05	CcSEcCtD
Doxorubicin—Rash—Prednisolone—hematologic cancer	1.02e-06	2.22e-05	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—hematologic cancer	1.02e-06	2.22e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.02e-06	2.21e-05	CcSEcCtD
Doxorubicin—Malaise—Epirubicin—hematologic cancer	1.02e-06	2.21e-05	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—hematologic cancer	1.01e-06	2.2e-05	CcSEcCtD
Doxorubicin—Headache—Prednisolone—hematologic cancer	1.01e-06	2.2e-05	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—hematologic cancer	1.01e-06	2.2e-05	CcSEcCtD
Doxorubicin—Vertigo—Epirubicin—hematologic cancer	1.01e-06	2.2e-05	CcSEcCtD
Doxorubicin—Syncope—Epirubicin—hematologic cancer	1.01e-06	2.2e-05	CcSEcCtD
Doxorubicin—Leukopenia—Epirubicin—hematologic cancer	1.01e-06	2.19e-05	CcSEcCtD
Doxorubicin—Constipation—Prednisone—hematologic cancer	1.01e-06	2.19e-05	CcSEcCtD
Doxorubicin—Palpitations—Epirubicin—hematologic cancer	9.96e-07	2.17e-05	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—hematologic cancer	9.91e-07	2.15e-05	CcSEcCtD
Doxorubicin—Loss of consciousness—Epirubicin—hematologic cancer	9.9e-07	2.15e-05	CcSEcCtD
Doxorubicin—Dizziness—Triamcinolone—hematologic cancer	9.84e-07	2.14e-05	CcSEcCtD
Doxorubicin—Cough—Epirubicin—hematologic cancer	9.83e-07	2.14e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—hematologic cancer	9.82e-07	2.14e-05	CcSEcCtD
Doxorubicin—Convulsion—Epirubicin—hematologic cancer	9.76e-07	2.12e-05	CcSEcCtD
Doxorubicin—Infection—Methotrexate—hematologic cancer	9.76e-07	2.12e-05	CcSEcCtD
Doxorubicin—Nausea—Etoposide—hematologic cancer	9.74e-07	2.12e-05	CcSEcCtD
Doxorubicin—Hypertension—Epirubicin—hematologic cancer	9.73e-07	2.12e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisone—hematologic cancer	9.69e-07	2.11e-05	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—hematologic cancer	9.69e-07	2.11e-05	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—hematologic cancer	9.69e-07	2.11e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Methotrexate—hematologic cancer	9.63e-07	2.1e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—hematologic cancer	9.62e-07	2.09e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—hematologic cancer	9.61e-07	2.09e-05	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—hematologic cancer	9.61e-07	2.09e-05	CcSEcCtD
Doxorubicin—Arthralgia—Epirubicin—hematologic cancer	9.59e-07	2.09e-05	CcSEcCtD
Doxorubicin—Chest pain—Epirubicin—hematologic cancer	9.59e-07	2.09e-05	CcSEcCtD
Doxorubicin—Myalgia—Epirubicin—hematologic cancer	9.59e-07	2.09e-05	CcSEcCtD
Doxorubicin—Anxiety—Epirubicin—hematologic cancer	9.56e-07	2.08e-05	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—hematologic cancer	9.55e-07	2.08e-05	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—hematologic cancer	9.55e-07	2.08e-05	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—hematologic cancer	9.54e-07	2.08e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.53e-07	2.07e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—hematologic cancer	9.5e-07	2.07e-05	CcSEcCtD
Doxorubicin—Discomfort—Epirubicin—hematologic cancer	9.48e-07	2.06e-05	CcSEcCtD
Doxorubicin—Vomiting—Triamcinolone—hematologic cancer	9.46e-07	2.06e-05	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—hematologic cancer	9.38e-07	2.04e-05	CcSEcCtD
Doxorubicin—Dry mouth—Epirubicin—hematologic cancer	9.38e-07	2.04e-05	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—hematologic cancer	9.37e-07	2.04e-05	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—hematologic cancer	9.37e-07	2.04e-05	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—hematologic cancer	9.34e-07	2.03e-05	CcSEcCtD
Doxorubicin—Headache—Triamcinolone—hematologic cancer	9.32e-07	2.03e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—hematologic cancer	9.29e-07	2.02e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—hematologic cancer	9.29e-07	2.02e-05	CcSEcCtD
Doxorubicin—Confusional state—Epirubicin—hematologic cancer	9.27e-07	2.02e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—hematologic cancer	9.24e-07	2.01e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—hematologic cancer	9.24e-07	2.01e-05	CcSEcCtD
Doxorubicin—Oedema—Epirubicin—hematologic cancer	9.19e-07	2e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Epirubicin—hematologic cancer	9.19e-07	2e-05	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—hematologic cancer	9.18e-07	2e-05	CcSEcCtD
Doxorubicin—Infection—Epirubicin—hematologic cancer	9.13e-07	1.99e-05	CcSEcCtD
Doxorubicin—Shock—Epirubicin—hematologic cancer	9.05e-07	1.97e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Epirubicin—hematologic cancer	9.02e-07	1.96e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Epirubicin—hematologic cancer	9e-07	1.96e-05	CcSEcCtD
Doxorubicin—Tachycardia—Epirubicin—hematologic cancer	8.97e-07	1.95e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.95e-07	1.95e-05	CcSEcCtD
Doxorubicin—Skin disorder—Epirubicin—hematologic cancer	8.93e-07	1.94e-05	CcSEcCtD
Doxorubicin—Dizziness—Betamethasone—hematologic cancer	8.93e-07	1.94e-05	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—hematologic cancer	8.93e-07	1.94e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Epirubicin—hematologic cancer	8.89e-07	1.93e-05	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—hematologic cancer	8.89e-07	1.93e-05	CcSEcCtD
Doxorubicin—Nausea—Triamcinolone—hematologic cancer	8.84e-07	1.92e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—hematologic cancer	8.82e-07	1.92e-05	CcSEcCtD
Doxorubicin—Anorexia—Epirubicin—hematologic cancer	8.76e-07	1.91e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—hematologic cancer	8.76e-07	1.9e-05	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—hematologic cancer	8.73e-07	1.9e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—hematologic cancer	8.66e-07	1.88e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—hematologic cancer	8.65e-07	1.88e-05	CcSEcCtD
Doxorubicin—Hypotension—Epirubicin—hematologic cancer	8.59e-07	1.87e-05	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—hematologic cancer	8.58e-07	1.87e-05	CcSEcCtD
Doxorubicin—Vomiting—Dexamethasone—hematologic cancer	8.58e-07	1.87e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—hematologic cancer	8.54e-07	1.86e-05	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—hematologic cancer	8.51e-07	1.85e-05	CcSEcCtD
Doxorubicin—Rash—Betamethasone—hematologic cancer	8.51e-07	1.85e-05	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—hematologic cancer	8.5e-07	1.85e-05	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—hematologic cancer	8.5e-07	1.85e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.48e-07	1.84e-05	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—hematologic cancer	8.47e-07	1.84e-05	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—hematologic cancer	8.46e-07	1.84e-05	CcSEcCtD
Doxorubicin—Headache—Betamethasone—hematologic cancer	8.46e-07	1.84e-05	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—hematologic cancer	8.43e-07	1.83e-05	CcSEcCtD
Doxorubicin—Pain—Methotrexate—hematologic cancer	8.4e-07	1.83e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.38e-07	1.82e-05	CcSEcCtD
Doxorubicin—Pruritus—Prednisone—hematologic cancer	8.32e-07	1.81e-05	CcSEcCtD
Doxorubicin—Insomnia—Epirubicin—hematologic cancer	8.32e-07	1.81e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Epirubicin—hematologic cancer	8.26e-07	1.8e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Epirubicin—hematologic cancer	8.2e-07	1.78e-05	CcSEcCtD
Doxorubicin—Somnolence—Epirubicin—hematologic cancer	8.17e-07	1.78e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Methotrexate—hematologic cancer	8.1e-07	1.76e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Epirubicin—hematologic cancer	8.09e-07	1.76e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Prednisone—hematologic cancer	8.04e-07	1.75e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—hematologic cancer	8.03e-07	1.75e-05	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—hematologic cancer	8.02e-07	1.74e-05	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—hematologic cancer	8.02e-07	1.74e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Epirubicin—hematologic cancer	7.99e-07	1.74e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.94e-07	1.73e-05	CcSEcCtD
Doxorubicin—Fatigue—Epirubicin—hematologic cancer	7.93e-07	1.72e-05	CcSEcCtD
Doxorubicin—Constipation—Epirubicin—hematologic cancer	7.86e-07	1.71e-05	CcSEcCtD
Doxorubicin—Pain—Epirubicin—hematologic cancer	7.86e-07	1.71e-05	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—hematologic cancer	7.8e-07	1.7e-05	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—hematologic cancer	7.77e-07	1.69e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—hematologic cancer	7.77e-07	1.69e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—hematologic cancer	7.77e-07	1.69e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Epirubicin—hematologic cancer	7.58e-07	1.65e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Epirubicin—hematologic cancer	7.52e-07	1.64e-05	CcSEcCtD
Doxorubicin—Vomiting—Prednisone—hematologic cancer	7.47e-07	1.63e-05	CcSEcCtD
Doxorubicin—Rash—Prednisone—hematologic cancer	7.41e-07	1.61e-05	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—hematologic cancer	7.41e-07	1.61e-05	CcSEcCtD
Doxorubicin—Headache—Prednisone—hematologic cancer	7.36e-07	1.6e-05	CcSEcCtD
Doxorubicin—Urticaria—Epirubicin—hematologic cancer	7.3e-07	1.59e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Epirubicin—hematologic cancer	7.27e-07	1.58e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Epirubicin—hematologic cancer	7.27e-07	1.58e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Methotrexate—hematologic cancer	7.24e-07	1.57e-05	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—hematologic cancer	7.05e-07	1.53e-05	CcSEcCtD
Doxorubicin—Nausea—Prednisone—hematologic cancer	6.98e-07	1.52e-05	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—hematologic cancer	6.95e-07	1.51e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Epirubicin—hematologic cancer	6.77e-07	1.47e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Methotrexate—hematologic cancer	6.72e-07	1.46e-05	CcSEcCtD
Doxorubicin—Asthenia—Epirubicin—hematologic cancer	6.6e-07	1.43e-05	CcSEcCtD
Doxorubicin—Pruritus—Epirubicin—hematologic cancer	6.5e-07	1.41e-05	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—hematologic cancer	6.5e-07	1.41e-05	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	6.43e-07	0.000871	CbGdCrCtD
Doxorubicin—Diarrhoea—Epirubicin—hematologic cancer	6.29e-07	1.37e-05	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	6.28e-07	0.00085	CbGdCrCtD
Doxorubicin—Vomiting—Methotrexate—hematologic cancer	6.25e-07	1.36e-05	CcSEcCtD
Doxorubicin—Rash—Methotrexate—hematologic cancer	6.19e-07	1.35e-05	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—hematologic cancer	6.19e-07	1.35e-05	CcSEcCtD
Doxorubicin—Headache—Methotrexate—hematologic cancer	6.15e-07	1.34e-05	CcSEcCtD
Doxorubicin—Dizziness—Epirubicin—hematologic cancer	6.08e-07	1.32e-05	CcSEcCtD
Doxorubicin—Vomiting—Epirubicin—hematologic cancer	5.85e-07	1.27e-05	CcSEcCtD
Doxorubicin—Nausea—Methotrexate—hematologic cancer	5.84e-07	1.27e-05	CcSEcCtD
Doxorubicin—Rash—Epirubicin—hematologic cancer	5.8e-07	1.26e-05	CcSEcCtD
Doxorubicin—Dermatitis—Epirubicin—hematologic cancer	5.79e-07	1.26e-05	CcSEcCtD
Doxorubicin—Headache—Epirubicin—hematologic cancer	5.76e-07	1.25e-05	CcSEcCtD
Doxorubicin—Nausea—Epirubicin—hematologic cancer	5.46e-07	1.19e-05	CcSEcCtD
Doxorubicin—NOS3—Metabolism—PTEN—hematologic cancer	2.93e-07	1.22e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PIK3CA—hematologic cancer	2.92e-07	1.22e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MDM2—hematologic cancer	2.91e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NUP214—hematologic cancer	2.91e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—hematologic cancer	2.9e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1A—hematologic cancer	2.9e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—hematologic cancer	2.9e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—hematologic cancer	2.9e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYCS—hematologic cancer	2.89e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	2.87e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3R1—hematologic cancer	2.85e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTR—hematologic cancer	2.85e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCG2—hematologic cancer	2.85e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAP2K1—hematologic cancer	2.84e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NUP98—hematologic cancer	2.84e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK8—hematologic cancer	2.83e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CB—hematologic cancer	2.83e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MTOR—hematologic cancer	2.83e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CD—hematologic cancer	2.83e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.82e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—hematologic cancer	2.82e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—hematologic cancer	2.81e-07	1.17e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO2—hematologic cancer	2.79e-07	1.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—hematologic cancer	2.79e-07	1.16e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—hematologic cancer	2.76e-07	1.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADCY7—hematologic cancer	2.76e-07	1.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOA3—hematologic cancer	2.76e-07	1.15e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CB—hematologic cancer	2.75e-07	1.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NUP214—hematologic cancer	2.74e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.73e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FHL2—hematologic cancer	2.72e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—hematologic cancer	2.71e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF2—hematologic cancer	2.71e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—hematologic cancer	2.7e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CG—hematologic cancer	2.69e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SRC—hematologic cancer	2.68e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTR—hematologic cancer	2.68e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCG2—hematologic cancer	2.68e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—hematologic cancer	2.68e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGRN—hematologic cancer	2.67e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3R1—hematologic cancer	2.67e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1B—hematologic cancer	2.66e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SDC1—hematologic cancer	2.65e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CB—hematologic cancer	2.63e-07	1.1e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO2—hematologic cancer	2.63e-07	1.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.63e-07	1.1e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—hematologic cancer	2.61e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CG—hematologic cancer	2.6e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—hematologic cancer	2.6e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—hematologic cancer	2.6e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JAK2—hematologic cancer	2.59e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—hematologic cancer	2.59e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—hematologic cancer	2.59e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—hematologic cancer	2.58e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—hematologic cancer	2.58e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—hematologic cancer	2.55e-07	1.07e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTP1—hematologic cancer	2.55e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.54e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—hematologic cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MDM2—hematologic cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—hematologic cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH2—hematologic cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMMR—hematologic cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUN—hematologic cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CREBBP—hematologic cancer	2.5e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SDC1—hematologic cancer	2.49e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK3—hematologic cancer	2.47e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—hematologic cancer	2.46e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CB—hematologic cancer	2.46e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTOR—hematologic cancer	2.46e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—hematologic cancer	2.46e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1A—hematologic cancer	2.45e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—hematologic cancer	2.45e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—hematologic cancer	2.44e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CREBBP—hematologic cancer	2.41e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—hematologic cancer	2.41e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—hematologic cancer	2.41e-07	1e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—hematologic cancer	2.4e-07	1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK8—hematologic cancer	2.39e-07	9.99e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—hematologic cancer	2.38e-07	9.95e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.38e-07	9.93e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.37e-07	9.91e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—hematologic cancer	2.37e-07	9.91e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CG—hematologic cancer	2.37e-07	9.89e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CD—hematologic cancer	2.37e-07	9.88e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NCOR1—hematologic cancer	2.34e-07	9.76e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—hematologic cancer	2.34e-07	9.76e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—hematologic cancer	2.34e-07	9.75e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—hematologic cancer	2.33e-07	9.74e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA9—hematologic cancer	2.31e-07	9.66e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACP5—hematologic cancer	2.31e-07	9.66e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1B—hematologic cancer	2.31e-07	9.65e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CD—hematologic cancer	2.29e-07	9.56e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.28e-07	9.54e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—hematologic cancer	2.28e-07	9.52e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—hematologic cancer	2.28e-07	9.5e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—hematologic cancer	2.27e-07	9.48e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SRC—hematologic cancer	2.27e-07	9.47e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—hematologic cancer	2.26e-07	9.45e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—hematologic cancer	2.26e-07	9.43e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CD44—hematologic cancer	2.25e-07	9.4e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NQO1—hematologic cancer	2.25e-07	9.4e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3R1—hematologic cancer	2.23e-07	9.33e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—hematologic cancer	2.22e-07	9.28e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—hematologic cancer	2.21e-07	9.22e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CREBBP—hematologic cancer	2.2e-07	9.17e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—hematologic cancer	2.19e-07	9.13e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—hematologic cancer	2.18e-07	9.11e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—hematologic cancer	2.18e-07	9.11e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH1—hematologic cancer	2.18e-07	9.08e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—hematologic cancer	2.17e-07	9.06e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3R1—hematologic cancer	2.16e-07	9.02e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TXN—hematologic cancer	2.15e-07	8.98e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.15e-07	8.98e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.15e-07	8.98e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1A—hematologic cancer	2.13e-07	8.91e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYCS—hematologic cancer	2.13e-07	8.89e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—hematologic cancer	2.13e-07	8.89e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NQO1—hematologic cancer	2.12e-07	8.85e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CD44—hematologic cancer	2.12e-07	8.85e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.12e-07	8.83e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.11e-07	8.79e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK3—hematologic cancer	2.09e-07	8.73e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.08e-07	8.69e-06	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—hematologic cancer	2.07e-07	8.63e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.07e-07	8.63e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—hematologic cancer	2.06e-07	8.62e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CB—hematologic cancer	2.06e-07	8.61e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—hematologic cancer	2.06e-07	8.58e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—hematologic cancer	2.04e-07	8.53e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—hematologic cancer	2.03e-07	8.49e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—hematologic cancer	2.03e-07	8.47e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—hematologic cancer	2.03e-07	8.47e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.02e-07	8.45e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—hematologic cancer	2.01e-07	8.4e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYCS—hematologic cancer	2.01e-07	8.38e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—hematologic cancer	2e-07	8.33e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CB—hematologic cancer	2e-07	8.33e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.99e-07	8.32e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—hematologic cancer	1.98e-07	8.25e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SRC—hematologic cancer	1.97e-07	8.24e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.97e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.97e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.97e-07	8.21e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.92e-07	8.01e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—hematologic cancer	1.9e-07	7.95e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—hematologic cancer	1.9e-07	7.93e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—hematologic cancer	1.89e-07	7.89e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—hematologic cancer	1.88e-07	7.84e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—hematologic cancer	1.88e-07	7.84e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NUP98—hematologic cancer	1.86e-07	7.75e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—hematologic cancer	1.86e-07	7.74e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK3—hematologic cancer	1.82e-07	7.59e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.82e-07	7.58e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—hematologic cancer	1.81e-07	7.55e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.8e-07	7.53e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.8e-07	7.53e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NUP214—hematologic cancer	1.79e-07	7.47e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—hematologic cancer	1.78e-07	7.44e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—hematologic cancer	1.77e-07	7.38e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.77e-07	7.38e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—hematologic cancer	1.76e-07	7.37e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.75e-07	7.32e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTR—hematologic cancer	1.75e-07	7.32e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CG—hematologic cancer	1.74e-07	7.25e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—hematologic cancer	1.73e-07	7.2e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NCOR1—hematologic cancer	1.72e-07	7.2e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—hematologic cancer	1.72e-07	7.2e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—hematologic cancer	1.72e-07	7.2e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO2—hematologic cancer	1.72e-07	7.18e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—hematologic cancer	1.7e-07	7.1e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—hematologic cancer	1.69e-07	7.04e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.67e-07	6.99e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—hematologic cancer	1.67e-07	6.99e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—hematologic cancer	1.67e-07	6.97e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.67e-07	6.97e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—hematologic cancer	1.67e-07	6.97e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—hematologic cancer	1.64e-07	6.86e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—hematologic cancer	1.63e-07	6.82e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SDC1—hematologic cancer	1.63e-07	6.81e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.63e-07	6.79e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.63e-07	6.79e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.61e-07	6.72e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—hematologic cancer	1.6e-07	6.7e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—hematologic cancer	1.6e-07	6.67e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—hematologic cancer	1.57e-07	6.55e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—hematologic cancer	1.53e-07	6.38e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.53e-07	6.37e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—hematologic cancer	1.52e-07	6.36e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—hematologic cancer	1.51e-07	6.29e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—hematologic cancer	1.5e-07	6.27e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—hematologic cancer	1.5e-07	6.25e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.44e-07	6.02e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.44e-07	6e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—hematologic cancer	1.41e-07	5.89e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—hematologic cancer	1.39e-07	5.8e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CD44—hematologic cancer	1.39e-07	5.79e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NQO1—hematologic cancer	1.39e-07	5.79e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—hematologic cancer	1.37e-07	5.71e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.33e-07	5.56e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—hematologic cancer	1.33e-07	5.55e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYCS—hematologic cancer	1.31e-07	5.48e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—hematologic cancer	1.31e-07	5.47e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.3e-07	5.44e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.28e-07	5.35e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—hematologic cancer	1.26e-07	5.25e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—hematologic cancer	1.23e-07	5.12e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—hematologic cancer	1.22e-07	5.08e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.21e-07	5.04e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CREBBP—hematologic cancer	1.19e-07	4.96e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.16e-07	4.83e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—hematologic cancer	1.15e-07	4.8e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.13e-07	4.7e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.12e-07	4.67e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—hematologic cancer	1.11e-07	4.64e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.11e-07	4.62e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—hematologic cancer	1.1e-07	4.58e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.09e-07	4.57e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.06e-07	4.44e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.06e-07	4.44e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.06e-07	4.44e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.06e-07	4.43e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—hematologic cancer	1.05e-07	4.37e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—hematologic cancer	1.03e-07	4.29e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1e-07	4.18e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—hematologic cancer	9.94e-08	4.15e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CB—hematologic cancer	9.81e-08	4.1e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—hematologic cancer	9.39e-08	3.92e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	9.25e-08	3.86e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—hematologic cancer	9.04e-08	3.77e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—hematologic cancer	8.48e-08	3.54e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—hematologic cancer	8.11e-08	3.39e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—hematologic cancer	8.09e-08	3.38e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—hematologic cancer	7.99e-08	3.34e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.89e-08	3.29e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—hematologic cancer	7.62e-08	3.18e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CREBBP—hematologic cancer	7.32e-08	3.05e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.94e-08	2.9e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—hematologic cancer	6.85e-08	2.86e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—hematologic cancer	6.63e-08	2.77e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	6.55e-08	2.73e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.05e-08	2.52e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.98e-08	2.5e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	5.64e-08	2.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—hematologic cancer	5.23e-08	2.18e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—hematologic cancer	4.98e-08	2.08e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—hematologic cancer	4.89e-08	2.04e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—hematologic cancer	4.61e-08	1.92e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.69e-08	1.54e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—hematologic cancer	3.01e-08	1.26e-06	CbGpPWpGaD
